Critical Path Institute

Certara, Critical Path Institute partner

Wednesday, September 11, 2013 01:33 PM

Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, is partnering with the independent nonprofit Critical Path Institute (C-Path) to develop a physiologically-based pharmacokinetic (PBPK) model of the human lung.

More... »

C-Path names Martha Brumfield as CEO

Tuesday, February 26, 2013 11:58 AM

The board of directors of the Critical Path Institute (C-Path), an independent, nonprofit organization, have named Martha Brumfield, Ph.D., as interim president and CEO. Brumfield, C-Path’s former director of international and regulatory programs, will take over immediately for Carolyn Compton, M.D., Ph.D. who will be assuming a new position at Arizona State University (ASU).

More... »

Exco InTouch joins C-Path ePRO Consortium

Wednesday, February 6, 2013 12:10 PM

Exco InTouch, a provider of patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, a program run by nonprofit Critical Path Institute (C-Path), which strives to enhance the quality of patient reported outcomes (PRO) in the evaluation of new pharmaceuticals. 

More... »

CDISC names additions to board of directors

Friday, January 25, 2013 12:27 PM

CDISC, a global, open, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata, has named five highly qualified individuals that will add invaluable expertise to the CDISC board of directors (BoD) for a three-year term beginning this month (2013–2016): Dr. Carolyn Compton, Michael Glickman, Dr. Douglas Peddicord, Stephen Pyke and John Speakman.

More... »

10 pharmas form nonprofit TransCelerate to accelerate R&D of new medicines

Wednesday, September 19, 2012 02:46 PM

Ten biopharmaceutical companies have formed a non-profit organization, TransCelerate BioPharma, to accelerate the development of new medicines. Participants include Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi.

More... »

C-Path and CDISC launch CFAST

Friday, September 14, 2012 12:35 PM

The Clinical Data Interchange Standards Consortium (CDISC), a global non-profit charitable organization, and Critical Path Institute (C-Path), a Tucson, Ariz.-based non-profit organization committed to improving human health and well-being, have launched their joint Coalition For Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year.

More... »

Bracket joins ePRO Consortium, program of Critical Path Institute

Friday, March 2, 2012 07:07 AM

Bracket, a division of UBC, has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, which seeks to improve the quality of patient reported outcomes, a crucial element in the drug development process.

More... »